Share information

Efficient diagnostics for better treatment decisions

Gentian is a company listed on Euronext Oslo Børs as GENT.

Latest share price development, trade volumes and other share information can be found on Euronext.

A full overview of shareholders including nominee accounts in accordance with the SRDII requirements

was last updated per 16 February 2026 and is available upon request at invest@gentian.no

Top 20 shareholders

30.09.2026

Shareholder No of Shares %
Ima Equity AS 2,110,224 13.65%
Kvantia AS 1,803,368 11.67%
Carpe Diem Afseth AS 1,000,000 6.47%
Norda ASA 716,099 4.63%
Safrino AS 649,700 4.20%
DNB Carnegie Investment Bank AB 645,621 4.18%
Insr ASA 614,251 3.97%
J.P. Morgan SE 600,000 3.88%
DNB Bank ASA, Meglerkonto Innland 571,169 3.69%
Verdipapirfondet Delphi Norge 389,572 2.52%
Intertrade Shipping AS 360,000 2.33%
Krefting, Johan Henrik 325,100 2.10%
Verdipapirfondet DNB Smb 304,097 1.97%
Alfaplan AS 303,000 1.96%
Manheim, Joachim Fasting 237,939 1.54%
Lioness AS 220,000 1.42%
Marstal AS 212,407 1.37%
T.D. Veen AS 195,000 1.26%
Skandinaviska Enskilda Banken AB 180,000 1.16%
Caaby AS 173,500 1.12%
Other Shareholders 3,847,577 24.89%
Total Shares 15 458 624 100 %

Primary insiders 

Name and position of primary insiders can be found on Euronext.

Gentian Diagnostics ASA - Prospectus

ACCESS HERE

IR Contact

Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525